Recce Pharmaceuticals Ltd.ASX: RCE

Independent Review of Indonesian Phase 3 R327G Trial Data

· Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Patient recruitment and dosing are ongoing while the DMC prepares its recommendations, which are expected to be available following their meeting. The company will provide a market update after receiving the DMC's formal recommendations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases